by Ellen Troyer, MT MA, with Spencer Thornton, MD Evidence continues to mount that links B vitamins deficiency, specifically B6, B12 and folate, to increased risk of developing Macular Degeneration and Alzheimer’s, as well as faster progression of the two disease processes. PLoS One, the open-access journal for the communication of all peer-reviewed scientific and [Read More]
News
Predictors of Advanced AMD Defined
According to members of the Three Continent AMD Consortium (3CC), prediction models for age-related macular degeneration (AMD) based on case-control studies have a tendency to overestimate risks. To provide more well-defined data, 3CC developed a prediction model for late AMD based on data from population-based studies. Using data from the Rotterdam Study, the Beaver Dam [Read More]
Riding the AMD Roller Coaster
Why do we see on some days worse than on others? by Dan Roberts Editor-in-Chief, Low Vision Resources Gradual vision loss is to be expected with age-related macular degeneration (AMD). Even though it is expected, however, slow deterioration of our view of the world can cause fear, depression, and chronic stress in those of us [Read More]
I Can’t See What You’re Saying
When the link breaks between sight and sound by Dan Roberts, Editor-in-Chief PBA Low Vision Resource Center Why do we visually impaired people also seem to have trouble understanding speech? Do we really need people to speak louder to us, as they are often prone to do? The answer may come from recent findings at [Read More]
New Drug Effective in Treating Vitreous Traction
Early treatment with a new drug called JETREA® (formerly called ocriplasmin) has shown effectiveness in lessening the risk of macular pucker, macular hole, and vitreomacular traction (VMT). These conditions are caused by the tugging on the macula by the vitreous gel, which is attached to the retina at several points. As the vitreous shrinks with [Read More]